Drug Channels

OCTOBER 13, 2022

pharmaceutical distribution, payment, and reimbursement system. The other is my mapping of the insurer/PBM/specialty pharmacy/provider organizations that now dominate U.S. But there are two slides that people seem to appreciate the most. One is my chart showing the key channel flows within the entire U.S. drug channels.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

MAY 9, 2022

Informa Connect’s Hub and Specialty Pharmacy Models East. June 28-30, 2022 | Sheraton Parsippany | Parsippany, NJ www.informaconnect.com/hub-specialty-pharmacy. Attorney’s Office, District of New Jersey Lauren Powell, MPA, PhD, Vice President, US Health Equity & Community Wellness, Takeda Pharmaceuticals PLUS! Attorney, U.S.

Specialty Pharmacies 75

Specialty Pharmacies Pharmacy Pharmaceuticals Government 75

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. The Essence of Pharmacognosy: Nature’s Pharmacy Unveiled Imagine walking through a lush rainforest, surrounded by countless plant species. What is a Drug Patent?

Drugs 97

Drugs Drug Development Pharmaceuticals Production 97

Drug Channels

MARCH 14, 2022

Asembia’s Specialty Pharmacy Summit 2022. Asembia's Specialty Pharmacy Summit 2022 is back! This is a must-attend event for anyone connected to specialty pharmacy. Plus, Doug Long from IQVIA and I will again lead the Featured Session, titled The Specialty Pharmacy Industry Update and Outlook. Gottlieb’s excellent book.

Specialty Pharmacies 74

Specialty Pharmacies Pharmacy FDA Science 74

FDA Law Blog: Biosimilars

DECEMBER 4, 2023

Houck — Separate decisions by federal district courts in Texas and Puerto Rico in the past two months provide cautionary tales for every pharmacy and wholesale distributor dispensing or distributing controlled substances. This post examines the Zarzamora pharmacy and prescribing red flags decision. d/b/a CVS/Pharmacy, Nos.

Pharmacy 139

Pharmacy Government Treatment Compliance 139

FDA Law Blog: Biosimilars

MAY 30, 2024

Kirschenbaum — Last week, the United States Court of Appeals for the District of Columbia ruled that Section 340B of the Public Health Service Act does not prohibit pharmaceutical manufacturers from imposing conditions on the distribution of discounted drugs to covered entities in the program. Novartis Pharmaceuticals v.

Pharmacy 59

Pharmacy Pharmaceuticals Drugs Government 59

Drug Patent Watch

OCTOBER 15, 2024

Have you ever found yourself scratching your head at the pharmacy counter, wondering why your “3-month supply” of medication doesn’t quite match up with the calendar? In this article, we’ll dive deep into this pharmaceutical conundrum… Source You’re not alone.

Pharmacy 110

Pharmacy Pharmaceuticals 110

Drug Channels

OCTOBER 21, 2024

Informa Connect’s Trade and Channel Strategies December 10-12, 2024 at the W Hotel in Philadelphia, PA Drug Channels readers save 10% with code 24DC10 * Pharmacy and distribution models are growing increasingly complex. Is my organization haemorrhaging money to stay afloat with the shift to alternative distribution and pharmacy models?

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Marketing Compliance 98

The Pharma Data

AUGUST 17, 2020

Amazon has entered the pharmaceutical market by launching ‘Amazon Pharmacy’ in India. . The Amazon Pharmacy offers prescription and over the counter drugs as well as basic health devices. . Amazon first entered pharmaceuticals in 2017, and bought the home pharmaceutical delivery service ‘PilPack’ in 2018.

Pharmacy 52

Pharmacy Pharmaceuticals Marketing Drugs 52

Drug Channels

OCTOBER 9, 2024

distribution and dispensing channels for prescription drugs are undergoing significant evolution and consolidation as the changing economics of pharmaceuticals challenge conventional business models. Read on for five key pricing, pharmacy, provider, and manufacturer trends that are driving the U.S. drug wholesaling industry.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

Drug Channels

OCTOBER 2, 2024

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. The 340B contract pharmacy market shows little sign of slowing down. For an updated look at what’s next for the 340B contract pharmacy market, join Adam J.

Pharmacy 52

Pharmacy Specialty Pharmacies Hospitals Marketing 52

Drug Channels

SEPTEMBER 21, 2022

In 2022, specialty pharmacies—via white, brown, and clear bagging—now constitute a meaningful share of the distribution channels for provider-administered oncology drugs. However, buy-and-bill appears to have rebounded substantially at hospitals. Read on for full details and the latest data.

Specialty Pharmacies 97

Specialty Pharmacies Hospitals Pharmacy Pharmaceuticals 97

FDA Law Blog: Biosimilars

MARCH 24, 2024

By Faraz Siddiqui — As drug manufacturers battle the Health Resources and Services Administration (“HRSA”) in federal courts over the role of 340B contract pharmacies, an Eighth Circuit decision to uphold a 2021 Arkansas law may render those cases inconsequential in that state. Code Ann. § 23-92-604(c)(1), (2) (Act 1103). McClain , No.

Pharmacy 59

Pharmacy Regulations Compliance Drugs 59

Drug Channels

APRIL 8, 2022

Michael discusses patient support challenges that are unique to specialty-lite pharmaceuticals. He goes on to describe four new categories of patient solutions and pharmacy models specific to this growing market segment.

Specialty Pharmacies 96

Specialty Pharmacies Production Pharmacy Therapies 96

Drug Channels

OCTOBER 2, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on DCI's new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. Click here to see the original post from May 2023. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence.

Pharmacy 97

Pharmacy Pharmaceuticals Marketing Drugs 97

Drug Channels

SEPTEMBER 2, 2020

This week, I’m rerunning some popular posts while I work on the forthcoming 2020-21 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. I'm rerunning this post to provide context for manufacturers' recent actions regarding 340B contract pharmacies. per 3 mL pen or $0.10 per 10 mL vial.

Pharmacy 52

Pharmacy Government Hospitals Pharmaceuticals 52

Drug Channels

OCTOBER 3, 2023

This week, I’m rerunning some popular posts while I put the finishing touches on our new 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This month, nine biosimilar versions of adalimumab launched in the U.S. No biosimilar has the trifecta of being high-concentration, citrate-free, and fully interchangeable.

Biosimilars 98

Biosimilars Pharmacy Marketing Pharmaceuticals 98

Drug Channels

OCTOBER 11, 2022

I am pleased to announce our new 2022–23 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. examines how the Inflation Reduction Act could ultimately impact pharmaceutical wholesalers’ customers and business outlook.

Pharmaceuticals 74

Pharmaceuticals Biosimilars Licensing Licensing 74

Drug Channels

OCTOBER 5, 2021

I am pleased to announce our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors , available for purchase and immediate download. pharmaceutical distribution industry. So, you can find out what your customers, partners, and competitors are reading.

Pharmaceuticals 75

Pharmaceuticals Biosimilars Licensing Licensing 75

Drug Channels

MAY 24, 2023

In recent years, each of these companies has launched new group purchasing organizations (GPOs) to further consolidate the number of covered lives in rebate negotiations with pharmaceutical manufacturers. Today, I examine these PBM-owned GPOs and then speculate on five plausible explanations for their existence.

Pharmacy 98

Pharmacy Pharmaceuticals Marketing Drugs 98

Drug Channels

APRIL 8, 2024

We intend to bring together people from the entire drug channel: pharmaceutical manufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more.

Pharmacy 97

Pharmacy Drugs Government Pharmaceuticals 97

National Drug & Alcohol Research Centre Blog

DECEMBER 4, 2023

In Australia, both methadone and buprenorphine have been subsidised by the Pharmaceutical Benefit Scheme (PBS) for the treatment of opioid dependence (termed ‘opioid agonist treatment’ or OAT) for several decades. The use of opioid agonist treatment increased in non-community pharmacy settings from early 2020.

Treatment 133

Treatment Community Pharmacies Pharmacy International 133

Drug Channels

AUGUST 8, 2023

on the overall market, explained channel distortions from 340B contract pharmacies, and offered some policy recommendations. Click here to read the full letter. I submitted a 14-page letter, which you can read below. I shared my $0.02 How could I not? Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Pharmacy 96

Pharmacy Hospitals Drugs Pharmaceuticals 96

Drug Channels

JULY 29, 2022

Note that the forecasts below did not account for policy changes that could further reduce pharmaceuticals' share of U.S. As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. healthcare spending. spending on healthcare.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

OCTOBER 25, 2021

Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This chart complements Follow the Dollar: The U.S. d/b/a Drug Channels Institute.

Pharmacy 97

Pharmacy Drugs Pharmaceuticals Hospitals 97

Drug Channels

APRIL 21, 2022

Pharmacy Distribution and Reimbursement System for Patient-Administered, Outpatient Brand-name Drugs. This post is adapted from Chapter 3 of our new 2021–22 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors. This chart complements Follow the Dollar: The U.S. d/b/a Drug Channels Institute.

Pharmacy 98

Pharmacy Drugs Pharmaceuticals Hospitals 98

SCIENMAG: Medicine & Health

OCTOBER 31, 2023

— A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys. BINGHAMTON, N.Y.

FDA Approval 83

FDA Approval FDA Disease Pharmacy 83

Drug Channels

JUNE 1, 2020

Like many of you, I was disappointed that Asembia had to cancel its 2020 Specialty Pharmacy Summit. You can view them for FREE if your registration to the 2020 Specialty Pharmacy Summit was transferred to the 2021 Summit. Click here to register for access to Asembia’s Specialty Pharmacy Summit Virtual Experience.

Specialty Pharmacies 40

Specialty Pharmacies Pharmacy Pharmaceuticals Marketing 40

SCIENMAG: Medicine & Health

AUGUST 21, 2023

professor of pharmaceutical sciences in the Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences and of pharmacology in Wayne State’s School of Medicine, received a $3 million, five-year award from the National Institute of Environmental Health Sciences of the National Institutes of Health.

Pharmacy 80

Pharmacy Disease Research Science 80

Drug Channels

APRIL 12, 2022

As you will see below, outpatient prescription drugs dispensed by retail and mail pharmacies are projected to remain a small share (8.4%) of total U.S. Thus, the government actuaries expect that pharmaceuticals will not be the key driver of U.S. healthcare spending. healthcare spending growth.

Pharmacy 98

Pharmacy Drugs Government Pharmaceuticals 98

Drug Channels

OCTOBER 27, 2021

Recent posts have covered: Walgreens’ new direction; controversary over independent pharmacy counting; insurer consolidation; retail pharmacy M&A; drug pricing policy; Prime Therapeutics; 340B contract pharmacy litigation; pharmaceutical antitrust; oncology care model; and Peter Bach’s nuptials.

Biosimilars 75

Biosimilars Hospitals Independent Pharmacies Pharmacy 75

Drug Channels

SEPTEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. Time for our annual update on the channels for provider-administered drugs. Read more » Copyright © 2006-2023 Pembroke Consulting, Inc. d/b/a Drug Channels Institute.

Specialty Pharmacies 97

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 97

Drug Channels

DECEMBER 13, 2023

For 2023, specialty pharmacies—via white, brown, and clear bagging—retained a meaningful share of the distribution channels for provider-administered oncology drugs. This week, I’m rerunning some popular posts while I prepare for Fiday's Drug Channels Outlook 2024 live video webinar. d/b/a Drug Channels Institute.

Specialty Pharmacies 98

Specialty Pharmacies Pharmacy Pharmaceuticals Drugs 98

Drug Channels

MAY 22, 2023

WHAT YOU WILL LEARN As expensive specialty therapies come to dominate drug spending, pharmaceutical manufacturers are paying a growing share of patents’ out-of-pocket costs for these prescriptions. Pharmacies and Pharmacy Benefit Managers. This event is part of The Drug Channels 2023 Video Webinar Series.

Pharmacy 97

Pharmacy Drugs Marketing Therapies 97

Alta Sciences

DECEMBER 14, 2023

A Closer Look At Our On-Site Compounding Pharmacies shajjar Thu, 12/14/2023 - 21:30 HTML Altasciences' dedicated pharmacists bring a wealth of expertise in controlled substances and complex compounding, ensuring maximum precision and safety standards. Electronic security access to the pharmacy and video monitoring. -

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

Policy Prescription

OCTOBER 3, 2023

Salant’s paper supports personal drug importation and legalizing the importation of prescription drugs for commercial use so that wholesale pharmacies, including companies like Amazon and Costco, could tap into the parallel importation markets of other countries. pharmacies and personal imports from India can be safe as well.

Pharmacy 84

Pharmacy International FDA Approval Government 84

The Pharma Data

SEPTEMBER 21, 2020

Acella Pharmaceuticals is recalling two types of its thyroid medication as the drugs may be too weak to properly treat those who take them. . Photo by Adam from UK. This follows a similar recall of thyroid medications that was issued by the FDA in recent weeks.

Pharmaceuticals 52

Pharmaceuticals Pharmacy Drugs Doctors 52